JPRN-jRCT2080221729未知1 期
A Randomized, Placebo-Controlled, Double-Blinded, Multiple Dose Escalation Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-823778 in Healthy Subjects and Patients with Type 2 Diabetes Mellitus
Bristol-Myers K.K.0 个研究点目标入组 40 人开始时间: 2012年3月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 65age old（—）
- 性别
- All
入选标准
- •for T2DM patients:
- •- Japanese patients with Type 2 Diabetes Mellitus (Fasting glucose < 240 mg/dL, HbA1c: 6.5% to 10.0% (NGSP)) who are treatment-naive and managed with diet and/or exercises only.
排除标准
- •for T2DM patients:
- •- Patient who is taking any medication for T2DM
- •- Symptoms of poorly controlled diabetes that would preclude participation in this placebo-controlled trial
- •- Insulin therapy within one year of screening
研究者
相似试验
进行中（未招募）
1 期
The metastatic castration-resistant prostate cancer (mCRPC) patients with homologous recombination repair (HRR) gene alterations who have notprogressed after docetaxel therapymetastatic castration-resistant prostate cancer (mCRPC)MedDRA version: 21.1Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: LLTClassification code 10076506Term: Castration-resistant prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2021-001205-73-ITIMPACT Therapeutics Inc.165
尚未招募
不适用
Stay-On oral liquid for prospective sexual functioCTRI/2017/03/008158SHREE MARUTI HERBA26
进行中（未招募）
3 期
Study to Assess the Effects of Deglusterol on Fasting Glucose and Other Cardiometabolic Risk Factors.CTRI/2023/01/048723Caregen Co., Ltd.
进行中（未招募）
1 期
Study of the safety of BMS-986259 in participants with post-acute decompensated heart failureHeart failureEUCTR2019-004186-40-GRBristol-Myers Squibb International Corporation72
尚未招募
Unknown
A comparative clinical study to evaluate a product in Iron Deficiency SubjectsCTRI/2023/06/053923Akay Natural Ingredients Pvt. Ltd.